Literature DB >> 16381181

Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes.

Frances Weaver1, Kenneth Follett, Kwan Hur, Dolores Ippolito, Matthew Stern.   

Abstract

OBJECT: Deep brain stimulation (DBS) to treat advanced Parkinson disease (PD) has been focused on one of two anatomical targets: the subthalamic nucleus (STN) and the globus pallidus internus (GPI). Authors of more than 65 articles have reported on bilateral DBS outcomes. With one exception, these studies involved pre- and postintervention comparisons of a single target. Despite the paucity of data directly comparing STN and GPI DBS, many clinicians already consider the STN to be the preferred target site. In this study the authors conducted a metaanalysis of the existing literature on patient outcomes following DBS of the STN and the GPI.
METHODS: This metaanalysis includes 31 STN and 14 GPI studies. Motor function improved significantly following stimulation (54% in patients whose STN was targeted and 40% in those whose GPI was stimulated), with effect sizes (ESs) of 2.59 and 2.04, respectively. After controlling for participant and study characteristics, patients who had undergone either STN or GPI DBS experienced comparable improved motor function following surgery (p = 0.094). The performance of activities of daily living improved significantly in patients with either target (40%). Medication requirements were significantly reduced following stimulation of the STN (ES = 1.51) but did not change when the GPI was stimulated (ES = -0.02).
CONCLUSIONS: In this analysis the authors highlight the need for uniform, detailed reporting of comprehensive motor and nonmotor DBS outcomes at multiple time points and for a randomized trial of bilateral STN and GPI DBS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16381181     DOI: 10.3171/jns.2005.103.6.0956

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  39 in total

1.  Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an Eastern center.

Authors:  Shang-Ming Chiou; Yu-Chin Lin; Ming-Kuei Lu; Chon-Haw Tsai
Journal:  Neurol Sci       Date:  2014-11-14       Impact factor: 3.307

Review 2.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 4.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

Review 5.  Deep brain stimulation: current and future clinical applications.

Authors:  Mark K Lyons
Journal:  Mayo Clin Proc       Date:  2011-06-06       Impact factor: 7.616

6.  Evaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.

Authors:  S Gulyani; R Salas; Z Mari; S Choi; A Mahajan; C Gamaldo
Journal:  Basal Ganglia       Date:  2016-05-27

Review 7.  Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature.

Authors:  Christoph van Riesen; Georg Tsironis; Doreen Gruber; Fabian Klostermann; Patricia Krause; Gerd Helge Schneider; Andreas Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2016-05-19       Impact factor: 3.575

8.  Somatotopic organization in the internal segment of the globus pallidus in Parkinson's disease.

Authors:  Kenneth B Baker; John Y K Lee; Gaurav Mavinkurve; Gary S Russo; Benjamin Walter; Mahlon R DeLong; Roy A E Bakay; Jerrold L Vitek
Journal:  Exp Neurol       Date:  2010-01-06       Impact factor: 5.330

9.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

10.  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.

Authors:  Michael S Okun; Hubert H Fernandez; Samuel S Wu; Lindsey Kirsch-Darrow; Dawn Bowers; Frank Bova; Michele Suelter; Charles E Jacobson; Xinping Wang; Clifford W Gordon; Pam Zeilman; Janet Romrell; Pam Martin; Herbert Ward; Ramon L Rodriguez; Kelly D Foote
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.